Quick Answer
Avalo Therapeutics, Inc. reported Stockholders Equity of $83.05 million for the year ending 2025.
- Avalo Therapeutics, Inc. showed a decrease of -37.6% in Stockholders Equity from 2024 to 2025.
- This data is from Avalo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2015: -$32.85 million | Q1 2016: $8.88 million | Q2 2016: $5.57 million | Q3 2016: $586.8 thousand | Q1 2017: -$425.8 thousand | Q2 2017: $3.14 million | Q3 2017: $22.12 million | Q1 2018: $24.58 million | Q2 2018: $19.22 million | Q3 2018: $19.51 million | Q1 2019: $23.12 million | Q2 2019: $17.70 million | Q3 2019: $18.22 million | Q1 2020: $25.59 million | Q2 2020: $50.58 million | Q3 2020: $38.57 million | Q1 2021: $33.16 million | Q2 2021: $21.59 million | Q3 2021: $40.31 million | Q1 2022: $6.34 million | Q2 2022: -$5.95 million | Q3 2022: -$2.03 million | Q1 2023: -$6.27 million | Q2 2023: -$6.97 million | Q3 2023: $14.70 million | Q1 2024: -$112.54 million | Q2 2024: -$13.61 million | Q3 2024: $21.08 million | Q1 2025: $122.62 million | Q2 2025: $104.57 million | Q3 2025: $91.55 million.
- Over the full 14 years of available data (2012 to 2025), Avalo Therapeutics, Inc.'s Stockholders Equity has grown by 829.7%.
- Historical annual values: Fiscal year 2025: $83.05 million | Fiscal year 2024: $133.03 million | Fiscal year 2023: $7.30 million | Fiscal year 2022: -$10.92 million | Fiscal year 2021: $23.08 million | Fiscal year 2020: $24.56 million | Fiscal year 2019: $21.00 million | Fiscal year 2018: $20.91 million | Fiscal year 2017: $27.86 million | Fiscal year 2016: $207.0 thousand | Fiscal year 2015: $13.08 million | Fiscal year 2014: -$26.33 million | Fiscal year 2013: -$17.85 million | Fiscal year 2012: -$11.38 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: